MRNAVSNPAC• 28 Days (Normalized)
MRNA vs NPAC (Moderna Inc. vs New Providence Acquisition Corp. III)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MRNA Performance $143.97
+127.37%
Moderna Inc.
Normalized Baseline0.00%
NPAC Performance $10.48
-0.1%
New Providence Acquisition Corp. III
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
+127.47%
MRNA outperforming by 127.47%
MRNANPAC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MRNA NPAC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | MRNA Price | MRNA Gain (%) | NPAC Price | NPAC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $143.97 | +127.37% | $10.48 | -0.10% | +127.47% |
| Sep 10, 2026 | $136.62 | +115.76% | $10.47 | -0.24% | +116.00% |
| Sep 09, 2026 | $135.61 | +114.17% | $10.47 | -0.20% | +114.37% |
| Sep 08, 2026 | $140.33 | +121.62% | $10.47 | -0.20% | +121.82% |
| Sep 04, 2026 | $145.55 | +129.86% | $10.49 | +0.00% | +129.86% |
| Sep 03, 2026 | $148.87 | +135.11% | $10.49 | +0.00% | +135.11% |
| Sep 02, 2026 | $150.81 | +138.17% | $10.48 | -0.10% | +138.27% |
| Sep 01, 2026 | $154.27 | +143.64% | $10.47 | -0.19% | +143.83% |
| Aug 31, 2026 | $140.34 | +121.64% | $10.45 | -0.38% | +122.02% |
| Aug 28, 2026 | $137.99 | +117.92% | $10.44 | -0.48% | +118.40% |
| Aug 27, 2026 | $142.77 | +125.47% | $10.47 | -0.24% | +125.71% |
| Aug 26, 2026 | $149.66 | +136.36% | $10.48 | -0.10% | +136.46% |
| Aug 25, 2026 | $158.83 | +150.84% | $10.47 | -0.23% | +151.07% |
| Aug 24, 2026 | $138.89 | +119.35% | $10.47 | -0.24% | +119.59% |
| Aug 21, 2026 | $145.13 | +129.20% | $10.47 | -0.24% | +129.44% |
Page 1 of 2